Biodexa Pharmaceuticals (BDRX)
NASDAQ: BDRX
· Real-Time Price · USD
1.30
0.01 (0.78%)
At close: May 14, 2025, 3:59 PM
1.30
-0.38%
After-hours: May 14, 2025, 05:36 PM EDT
0.78% (1D)
| Bid | 1.28 |
| Market Cap | 2.18K |
| Revenue (ttm) | 83K |
| Net Income (ttm) | -6.82M |
| EPS (ttm) | -13.29 |
| PE Ratio (ttm) | -0.1 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.62 |
| Volume | 61,210 |
| Avg. Volume (20D) | 1,603,941 |
| Open | 1.32 |
| Previous Close | 1.29 |
| Day's Range | 1.26 - 1.36 |
| 52-Week Range | 1.11 - 74.00 |
| Beta | 1.16 |
About BDRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BDRX
Website n/a
3 days ago
-12.77%
BDRX stock has given up its prior gain. Biodexa Ph...
Unlock content with
Pro Subscription
1 month ago
+12.74%
Biodexa Pharmaceuticals shares are trading higher after the company announced it expects the initiation of its Phase 3 registrations study of eRapa in FAP.
